Belite Bio, Inc (ADR)

General ticker "BLTE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.2B (TTM average)

Belite Bio, Inc (ADR) follows the US Stock Market performance with the rate: 42.2%.

Estimated limits based on current volatility of 3.2%: low 170.90$, high 182.16$

Factors to consider:

  • Earnings expected soon, date: 2026-03-16 bmo
  • Total employees count: 16 as of 2022
  • Current price 189.9% above estimated high
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [34.20$, 79.57$]
  • 2025-12-31 to 2026-12-31 estimated range: [23.89$, 59.52$]

Financial Metrics affecting the BLTE estimates:

  • Negative: with PPE of -53.3 at the end of fiscal year the price was very high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -1.52 <= 0.01
  • Positive: -14.22 < Investing cash flow per share per price, % of -5.76
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Shareholder equity ratio, % of 95.85 > 64.29
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term BLTE quotes

Long-term BLTE plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $12.82MM $31.67MM $40.00MM
Operating Income $-12.82MM $-31.67MM $-40.00MM
Non-Operating Income $0.17MM $0.04MM $3.86MM
Interest Expense $0.02MM $0.03MM $0.02MM
R&D Expense $8.87MM $24.84MM $29.94MM
Income(Loss) $-12.65MM $-31.62MM $-36.14MM
Taxes $0.00MM $0.01MM $0.01MM
Profit(Loss)* $-12.65MM $-31.63MM $-36.14MM
Stockholders Equity $41.50MM $90.43MM $145.82MM
Inventory $0.02MM $0.00MM $0.00MM
Assets $44.27MM $94.64MM $152.13MM
Operating Cash Flow $-11.46MM $-29.84MM $-29.23MM
Capital expenditure $0.39MM $0.06MM $0.15MM
Investing Cash Flow $-0.39MM $-0.06MM $-110.57MM
Financing Cash Flow $36.96MM $75.96MM $83.59MM
Earnings Per Share** $-0.63 $-1.19 $-1.18
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.